AmyT

dLife and the Diabetes Media Conundrum

“It used to be that anytime something — anything — about diabetes was on TV or in the news, everyone would call each other right away, word would spread fast and everyone was all excited.  But now there’s a weekly television show devoted specifically to diabetes and people shrug it off and say, ‘aw, that’s so commercial,’” Tom Karlya of dLife tells me with a sigh. 
I am sitting in his Westport, Ct., office.  (Yes,…

Read more »

A1c Celebration (?)

I should be celebrating — shouting from the rooftops!  But instead I am stunned. Confused.  Filled with skepticism.  Those of you who’ve been following my DexCom adventures here know how frustrated I was when I couldn’t seem to get my A1c below 7.1, despite a lot of diligence and aggravation.
But something weird happened.  I had my A1c tested again about a month later, and about 10 days after I’d set the DexCom aside for…

Read more »

Very Rapid-Acting Insulin on the Fast Track

Thank you to Kelly Close, for the tip-off on the potential answer to many of our prayers.  I wrote recently about the compulsion to pre-inject for meals (20-30 min ahead of time at least) if you want to have a prayer of bringing down your post-meal blood sugars (without adding an additional injection of Symlin — which can cause lows and make insulin dosing especially tricky).  Pre-injecting works well indeed, but I need not elaborate…

Read more »

Riva Greenberg and the Diabetes Mentoring Imperative

Through the wonder of the Internet, it was hard to tell, but I was in New York last week –  visiting my various publishers (for our new KYN book, plus dLife and HealthCentral).  It was cold and crisp and holiday-sparkly and shopping heaven.  I have so much to report!  Where to begin?  Allow me to start with Riva Greenberg, please.
Riva’s been a Type 1 for 35 years. She’s a writer and an illustrator and…

Read more »

What’s Up with the Celiac/T1 Diabetes Pill?

I’m not sure how I missed this one last Spring, but a certain Dr. Alessio Fasano of the University of Maryland Center for Celiac Research in Baltimore helped kick off some super-exciting research on a pill that could “put an end to off-limits foods for diabetics and celiacs.”
The pill, which works by decreasing the permeability of the intestines, is being developed by a spin-off startup company called Alba Therapeutics, where Dr. Fasano serves as…

Read more »